Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Aug. 31, 2022 |
Aug. 31, 2021 |
Aug. 31, 2022 |
Aug. 31, 2021 |
|
| Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) | ||||
| Revenue | $ 135,428 | $ 0 | $ 135,428 | $ 0 |
| Expenses : | ||||
| Research and development (Note 14) | 3,751,155 | 5,284,797 | 10,551,639 | 13,922,632 |
| General and administrative (Notes 15) | 4,010,687 | 3,116,226 | 15,047,328 | 6,276,797 |
| Depreciation and amortization (Notes 7 and 8) | 138,100 | 140,770 | 276,642 | 272,770 |
| Interest and other financial expenses (Note 19) | 43,230 | 33,102 | 84,559 | 63,689 |
| Interest income | (9,334) | (8,413) | (22,527) | (18,174) |
| Foreign exchange loss (gain) | (93,244) | (174,066) | (91,108) | 32,066 |
| Total expenses | 7,840,594 | 8,392,416 | 25,846,535 | 20,549,780 |
| Net loss | (7,705,166) | (8,392,416) | (25,711,105) | (20,549,780) |
| Other comprehensive income (loss) | ||||
| Foreign currency translation adjustment | (412,504) | (353,713) | (417,270) | (146,898) |
| Comprehensive income (loss) | $ (8,117,670) | $ (8,746,129) | $ (26,128,375) | $ (20,696,678) |
| Loss per share Basic and diluted | $ (0.16) | $ (0.19) | $ (0.54) | $ (0.47) |
| Weighted average common shares outstanding Basic and diluted | 47,400,709 | 44,132,872 | 47,400,640 | 43,282,989 |